Bone morphogenetic protein-induced inflammatory cyst formation after lumbar fusion causing nerve root compression Case report

被引:26
作者
Choudhry, Osamah J. [1 ]
Christiano, Lana D. [1 ]
Singh, Rahul [1 ]
Golden, Barbara M. [2 ]
Liu, James K. [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Neurol Inst New Jersey, Newark, NJ 07101 USA
[2] NorthShore Univ Hlth Syst, Evanston Hosp, Dept Pathol, Evanston, IL USA
关键词
bone morphogenetic protein; inflammatory cyst; complications; inflammation; lumbar; ILIAC-CREST AUTOGRAFT; ANTERIOR CERVICAL DISKECTOMY; INTERBODY FUSION; SAFETY PROFILE; SPINE SURGERY; FOLLOW-UP; ARTHRODESIS; EFFICACY; RHBMP-2; GRAFT;
D O I
10.3171/2011.11.SPINE11629
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Bone morphogenetic protein (BMP) has been reported to cause early inflammatory changes, ectopic bony formation, adjacent level fusion, radiculitis, and osteolysis. The authors describe the case of a patient who developed inflammatory fibroblastic cyst formation around the BMP sponge after a lumbar fusion, resulting in compressive lumbar radiculopathy. A 70-year-old woman presented with left L-4 and L-5 radiculopathy caused by a Grade I spondylolisthesis with a left herniated disc at L4-5. She underwent a minimally invasive transforaminal lumbar interbody fusion with BMP packed into the interbody cage at L4-5. Her neurological symptoms resolved immediately postoperatively. Six weeks later, the patient developed recurrence of radiculopathy. Radiological imaging demonstrated an intraspinal cyst with a fluid-fluid level causing compression of the left L-4 and L-5 nerve roots. Reexpoloration of the fusion was performed, and a cyst arising from the posterior aspect of the cage was found to compress the axilla of the left L-4 nerve root and the shoulder of the L-5 nerve root. The cyst was decompressed, and the wall was partially excised. A collagen BMP sponge was found within the cyst and was removed. Postoperatively, the patient's radiculopathy resolved and she went on to achieve interbody fusion. Bone morphogenetic protein can be associated with inflammatory cyst formation resulting in neural compression. Spine surgeons should be aware of this complication in addition to the other reported BMP-related complications. (DOI: 10.3171/2011.11.SPINE11629)
引用
收藏
页码:296 / 301
页数:6
相关论文
共 38 条
[1]
A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery [J].
Benglis, David ;
Wang, Michael Y. ;
Levi, Allan D. .
NEUROSURGERY, 2008, 62 (05) :423-431
[2]
Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2 [J].
Burkus, JK ;
Dorchak, JD ;
Sanders, DL .
SPINE, 2003, 28 (04) :372-377
[3]
Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages [J].
Burkus, JK ;
Gornet, MF ;
Dickman, CA ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2002, 15 (05) :337-349
[4]
Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion [J].
Buttermann, Glenn Robin .
SPINE JOURNAL, 2008, 8 (03) :426-435
[5]
Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft [J].
Dimar, John R. ;
Glassman, Steven D. ;
Burkus, Kenneth J. ;
Carreon, Leah Y. .
SPINE, 2006, 31 (22) :2534-2539
[6]
Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system [J].
Dmitriev, Anton E. ;
Lehman, Ronald A., Jr. ;
Symes, Aviva J. .
SPINE JOURNAL, 2011, 11 (06) :500-505
[7]
Formation of Painful Seroma and Edema After the Use of Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Lumbar Spine Fusions [J].
Garrett, Mark P. ;
Kakarla, Udaya K. ;
Porter, Randall W. ;
Sonntag, Volker K. H. .
NEUROSURGERY, 2010, 66 (06) :1044-1049
[8]
Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
[9]
Safety, Efficacy, and Dosing of Recombinant Human Bone Morphogenetic Protein-2 for Posterior Cervical and Cervicothoracic Instrumented Fusion With a Minimum 2-Year Follow-up [J].
Hamilton, D. Kojo ;
Smith, Justin S. ;
Reames, Davis L. ;
Williams, Brian J. ;
Chernavvsky, Daniel R. ;
Shaffrey, Christopher I. .
NEUROSURGERY, 2011, 69 (01) :103-111
[10]
Commentary: Important considerations on bone morphogenetic protein-2 and neuroinflammation [J].
Heggeness, Michael H. .
SPINE JOURNAL, 2011, 11 (06) :506-506